Education
About Us
Working with TipRanks
Follow Us
Innate Pharma SA (IPHYF)
OTHER OTC:IPHYF
See the Price Targets and Ratings of:
IPHYF Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Kepler Capital
$3.62
Hold
67.56%
Upside
Reiterated
05/23/25
Stifel Nicolaus
$6.65
Buy
208.09%
Upside
Reiterated
02/17/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Kepler Capital
$3.62
Hold
67.56%
Upside
Reiterated
05/23/25
Stifel Nicolaus
$6.65
Buy
208.09%
Upside
Reiterated
02/17/25
Best Analysts Covering Innate Pharma SA
1 Month
xxx
Success Rate
0/4 ratings generated profit
Average Return
-6.48%
reiterated a xxx
rating 11 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -6.48% per trade.
3 Months
xxx
Success Rate
1/4 ratings generated profit
Average Return
-14.20%
reiterated a xxx
rating 11 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of -14.20% per trade.
1 Year
Success Rate
1/4 ratings generated profit
Average Return
-6.75%
reiterated a buy rating 11 months ago
Copying Eric Le Berrigaud's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -6.75% per trade.
2 Years
xxx
Success Rate
1/4 ratings generated profit
Average Return
-19.38%
reiterated a xxx
rating 11 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 25.00% of your transactions generating a profit, with an average return of -19.38% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
IPHYF Analyst Recommendation Trends
Rating
Feb 25
Apr 25
May 25
Oct 25
Nov 25
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
6
3
4
10
12
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
3
4
10
12
Each month's total comprises the sum of three months' worth of ratings.
IPHYF Stock Forecast FAQ
What is IPHYF’s average 12-month price target, according to analysts?
Currently, no data Available
What is IPHYF’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IPHYF, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is IPHYF a Buy, Sell or Hold?
Innate Pharma SA has a consensus rating of Hold which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Innate Pharma SA’s price target?
Currently, no data Available
What do analysts say about Innate Pharma SA?
Innate Pharma SA’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of IPHYF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.